Abstract:Abstract Nutritional chemoprevention is a promising approach for prostate cancer (PCa) management. Resveratrol (Res), found in plants, has antioxidant, cardioprotective, anti-inflammatory and anticancer properties. Res may be considered as both a chemopreventive and chemotherapeutic agent on the basis of molecular and preclinical studies. We propose to investigate novel epigenetic mechanisms of the chemopreventive and anticancer effects of Res. We discovered that Res down-regulates metastasis-associated protein 1 (MTA1) by causing its proteasomal degradation. MTA1 levels correlate with cancer aggressiveness and metastases and, as a part of the nucleosome remodeling deacetylation (NuRD) complex, MTA1 plays a role in chromatin remodeling and transcriptional repression. We hypothesize that MTA1 nuclear overexpression promotes PCa progression and metastasis by enhancing MTA1/HDAC1/NuRD deacetylation activity. We further hypothesize that Res, as a potent inhibitor of MTA1, exerts its anticancer effects, at least in part, through blocking MTA1/HDAC1/NuRD-mediated deacetylation. We propose: (1) determine the effects of Res on MTA1-mediated epigenetic modifications of PTEN and HIF-1α. We will use PCa cells with silenced MTA1 (shRNA-mediated knockdown) to examine the acetylation state of PTEN and HIF-1α in the presence or absence of Res. Transcriptional activation/repression of downstream signaling (PI3K/Akt) or target genes (VEGF) will be used as readouts. (2) evaluate MTA1-associated epigenetic anticancer effects of Res analogues in PCa. We will compare biopotency of natural and synthetic Res analogues in inhibiting MTA1, cell proliferation, invasion and migration in vitro. (3) evaluate MTA1-mediated Res chemopreventive and therapeutic efficacy in PCa mouse models. a. we will use orthotopic PCa xenografts to evaluate MTA1-mediated effects of Res on PCa initiation, progression and metastasis; b. we will evaluate Res chemopreventive and therapeutic effects using autochthonous, prostate-specific Pten −/− mouse model. Our study is the first to identify MTA1 as a specific molecular target of Res, further defining a novel epigenetic mechanism of Res anticancer activity as an HDAC inhibitor. The mechanism-based studies will significantly contribute to a better understanding of the role of MTA1 as an upstream epigenetic regulator of tumor suppressors and oncogenes. The results from this study will aid the development of preventive and curative strategies based on Res, its potent analogues, and synergy with other “epigenetic” agents. Our preclinical studies will provide a powerful base for initiating clinical trials in men. Citation Information: Cancer Prev Res 2011;4(10 Suppl):B75.

Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts.

Pterostilbene Acts Through Metastasis-Associated Protein 1 To Inhibit Tumor Growth, Progression And Metastasis In Prostate Cancer

Abstract B75: Resveratrol and Its Analogues As Chemopreventive and Anticancer Agents in Prostate Cancer: Epigenetic Mechanisms of Action

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Resveratrol Suppresses the Epithelial-to-mesenchymal Transition in PC-3 Cells by Down-Regulating the PI3K/AKT Signaling Pathway

α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model

Combined Inhibitory Effects of Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient Mice.

Effect of Pterostilbene, a Natural Derivative of Resveratrol, in the Treatment of Colorectal Cancer through Top1/Tdp1-Mediated DNA Repair Pathway

Evaluation of Biophysical As Well As Biochemical Potential of Curcumin and Resveratrol During Prostate Cancer

A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.

Antitumor Effects of Naturally Occurring Oligomeric Resveratrol Derivatives

In Vitro Pro-Apoptotic and Anti-Migratory Effects of Marantodes pumilum (syn. Labisia pumila) Extracts on Human Prostate Cancer Cell Lines: Bioguided Isolation of 5-Henicosene-1-yl-resorcinol

Resveratrol Inhibits TRAF6/PTCH/SMO Signal and Regulates Prostate Cancer Progression

Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cells

Experimental Therapy of Prostate Cancer with Novel Natural Product Anti-Cancer Ginsenosides

Synthesis and Antitumor Activity of Bis(hydroxymethyl)propionate Analogs of Pterostilbene in Cisplatin-Resistant Human Oral Cancer Cells.

Bioassay-Guided Identification of the Antiproliferative Compounds of Cissus trifoliata and the Transcriptomic Effect of Resveratrol in Prostate Cancer Pc3 Cells

Chemoprevention of Prostate Cancer in TRAMP Mice by Dibenzoylmethane (DBM)

Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling

Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer Cells

Utilizing mixture design response surface methodology to determine effective combinations of plant derived compounds as prostate cancer treatments